These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 241249)
1. The effect epsilon-aminocaproic acid hydrochloride on influenza infection in mice. Hrusková J; Jarý J Acta Virol; 1975 Sep; 19(5):435-36. PubMed ID: 241249 [No Abstract] [Full Text] [Related]
2. Effectiveness of prophylactic administration of epsilon-amino caproic acid during influenza in mice. Puzis LE; Lozitsky VP; Polyak RYa Acta Virol; 1986 Jan; 30(1):58-62. PubMed ID: 2871734 [TBL] [Abstract][Full Text] [Related]
3. Effect of 60amino-6-deoxy-D-glucose hydrochloride on influenza infection in mice. Hrusková J; Jarý J; Danes L; Jelínková A; Novák M Acta Virol; 1975 Jan; 19(1):47-51. PubMed ID: 235197 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study of the prophylactic anti-influenza and interferon-inducing activity of epsilon-aminocaproic acid]. Kremerman IB; Priĭmiagi LS; Lozitskiĭ VP; Tefanova VT Antibiot Khimioter; 1988 Jan; 33(1):63-7. PubMed ID: 2454085 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic effects of murabutide in OF1 mice infected with influenza A/H3N2 (A/Texas/1/77) virus. Chomel JJ; Simon-Lavoine N; Thouvenot D; Valette M; Choay J; Chedid L; Aymard M J Biol Response Mod; 1988 Dec; 7(6):581-6. PubMed ID: 2851033 [TBL] [Abstract][Full Text] [Related]
6. Action of epsilon-aminocaproic acid on the proteolysis system during experimental influenza in mice. Puzis LE; Lozitsky VP Acta Virol; 1988 Nov; 32(6):515-21. PubMed ID: 2906223 [TBL] [Abstract][Full Text] [Related]
7. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography. Becker J; Borgström S; Saltzman GF Acta Chir Scand; 1970; 136(3):167-71. PubMed ID: 4103355 [No Abstract] [Full Text] [Related]
8. Resistance of mice to reinfection after E-aminocaproic acid treatment of primary influenza virus infection. Lozitsky VP; Puzis LE; Polyak RYa Acta Virol; 1988 Mar; 32(2):117-22. PubMed ID: 2899958 [TBL] [Abstract][Full Text] [Related]
9. [Epsilon-aminocaproic acid as an anti-allergic agents in surgical practice]. Zatikian LO Klin Med (Mosk); 1975 Nov; 53(11):103-6. PubMed ID: 1223500 [No Abstract] [Full Text] [Related]
10. [Administration of epsilon-aminocaproic acid]. Hrodek O Cesk Pediatr; 1968 May; 23(5):465-7. PubMed ID: 5660458 [No Abstract] [Full Text] [Related]
11. [Action of epsilon-aminocaproic acid as an anti-allergic agent and its effect on blood coagulation system]. Zatikian LO Zh Eksp Klin Med; 1973; 13(3):16-9. PubMed ID: 4791710 [No Abstract] [Full Text] [Related]
12. [Influenza vaccination: reinforcement of its effectiveness by combination with an immunostimulant]. German A; Fattal-German M; Quero AM; Bizzini B Bull Acad Natl Med; 1988 Mar; 172(3):467-74. PubMed ID: 3048551 [No Abstract] [Full Text] [Related]
13. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material. Becker J; Borgström S Acta Chir Scand; 1968; 134(5):343-9. PubMed ID: 5731268 [No Abstract] [Full Text] [Related]
14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010 [TBL] [Abstract][Full Text] [Related]
15. Modification of delayed skin reaction by epsilon-aminocaproic acid. Miller JM Exp Med Surg; 1971; 29(1):132-4. PubMed ID: 5147594 [No Abstract] [Full Text] [Related]
16. [Studies of 5-nitrofurfural acetals. 4. Antiviral effect of 5-nitro-2-furfural-diethyl acetal on the influenza virus A-PR8]. Kewitsch A; Weuffen W; Becker R Arch Exp Veterinarmed; 1968; 22(1):143-9. PubMed ID: 5681879 [No Abstract] [Full Text] [Related]
17. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780 [TBL] [Abstract][Full Text] [Related]